Type to search

Oncode Institute and ArgoBio Launch Laigo Bio, a Targeted Protein Degradation Biotech with Programs in Oncology and Neurological Disorders | Pharmtech Focus
Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement | Pharmtech Focus